Diabetic Gastroparesis Treatment Market Demand, Growth Prediction, Segments And Outlook By 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Diabetic Gastroparesis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $4.73 billion In 2028 At A CAGR Of 5.2%.

The diabetic gastroparesis treatment market size has grown strongly in recent years. It will grow from $3.68 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to increasing diabetes prevalence, limited treatment options, rising awareness and diagnosis, healthcare infrastructure development.

The diabetic gastroparesis treatment market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, growing diabetic population, increased research and development, shift in regulatory landscape. Major trends in the forecast period include technological innovations in treatments, emergence of novel therapies, focus on symptom management, telemedicine and remote monitoring, gut microbiome interventions.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12580&type=smp

Diabetic Gastroparesis Treatment Market Major Segments
The diabetic gastroparesis treatment market covered in this report is segmented -
1) By Treatment: Medication, Surgery
2) By Route Of Administration: Oral, Injectables
3) By Indication: Compensated Gastroparesis, Gastric Failure
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Key Driver - Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment Market

The increasing prevalence of diabetes is expected to propel the growth of the diabetic gastroparesis treatment market going forward. The prevalence of diabetes refers to the proportion or percentage of the population that has been diagnosed with diabetes at a specific point in time. The use of diabetic gastroparesis treatment is primarily aimed at managing the symptoms and complications associated with this condition, which is a common complication of diabetes. For instance, in April 2023, according to a report published by The British Diabetic Association, a UK-based diabetes charity, 4.3 million individuals in the UK have diabetes and live with it. Further, more than 2.4 million people in the UK are at high risk of acquiring type 2 diabetes, and registration numbers for 2021-22 are 148,951. Therefore, the increasing prevalence of diabetes is driving the growth of the diabetic gastroparesis treatment market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12580&type=smp

Prominent Trend - Surgical Advancements And Diabetic Gastroparesis Fueling Growth In Treatment Strategies

The rising number of surgical procedures is expected to propel the growth of the diabetic gastroparesis treatment market going forward. Surgery refers to a medical specialty and branch of medicine that involves the treatment of diseases, injuries, or conditions through operative procedures. Surgical procedures in diabetic patients that have caused post-surgical gastroparesis include Nissen fundoplication, gastrectomy, gastric bypass surgery, pancreatectomy, vagotomy, and cholecystectomy by injuring the vague nerve that coordinates food movement through the digestive tract. For instance, in April 2022, according to the Aesthetic Society, a US-based industry organization of plastic surgeons, surgical aesthetic procedures increased by 54% in 2021 as compared to 2020. On average, a surgeon performed 320 procedures in 2021, up from 220 procedures in 2020. Therefore, the rising number of surgical procedures drives the diabetic gastroparesis treatment market.

Diabetic Gastroparesis Treatment Market Players
Major companies operating in the diabetic gastroparesis treatment market report are Cardinal Health Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Ipca Laboratories Ltd., Abbott Laboratories, GlaxoSmithKline plc, AstraZeneca plc, Medtronics plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Kimberly-Clark Corporation, Teva Pharmaceutical Industries Ltd., Janssen Global Services LLC, Boston Scientific Corporation, Fresenius Kabi AG, Bausch Health Companies Inc., Allergan Inc., Salix Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Wockhardt Ltd., ANI Pharmaceuticals Inc., Endologic LLC, Vanda Pharmaceuticals Inc., Rhythm Pharmaceuticals Inc., Theravance Biopharma Inc., Neurogastrx Inc., Evoke Pharma Inc., CinRx Pharma LLC

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/diabetic-gastroparesis-treatment-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the diabetic gastroparesis treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic gastroparesis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Diabetic Gastroparesis Treatment Market Report Structure
3. Diabetic Gastroparesis Treatment Market Trends And Strategies
4. Diabetic Gastroparesis Treatment Market - Macro Economic Scenario
5. Diabetic Gastroparesis Treatment Market Size And Growth
…..
27. Diabetic Gastroparesis Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.